תבנית:תרופה/טבעפירין - Tevapirin

× ×ª×× × ×ª×¨××¤×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	B01AC Platelet aggregation inhibitors excluding heparin
××¨××× ×¤×¢×× (ATC5)	*Acetylsalicylic acid 100MG âB01AC06 Acetylsalicylic acid 100MG âB01AC06 Platelet aggregation inhibitors, excl. heparin B01AC âB01AC06 7290008097307 ×× âB01AC06 Northern industrial zone, pob 888 KIRYAT SHMONA, ISRAEL release âB01AC06 18, eli hurvitz street, industrial zone, kfar saba 44102, ISRAEL secondary packaging , primary packaging , bulk âB01AC06 Acetylsalicylic acid 100MG âB01AC06
×¦××¨×ª ××ª×	PER OS
×¦××¨×ª ××× ××	TABLETS ENTERIC COATED
××ª××××	The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/×××¢×¤××¨×× - Tevapirin

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¢×¤××¨×× Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
×©× ××¢× ××¨××©××	TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 07/2014. ×¨××©××× ××ª××¨××: 07/2014
×ª××¨×× ×¢×××× ×××¨××	21/08/17

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/×××¢×¤××¨×× - Tevapirin}}

×:

{{×ª×¨××¤×/×××¢×¤××¨×× - Tevapirin
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־21 באוגוסט 2017 ב־11:55

ויקיתרופות